TY - JOUR T1 - Essentials of cardio-oncology JF - Clinical Medicine JO - Clin Med SP - 52 LP - 55 DO - 10.7861/clinmed.2022-0588 VL - 23 IS - 1 AU - Vera Vaz Ferreira AU - Arjun K Ghosh Y1 - 2023/01/01 UR - http://www.rcpjournals.org/content/23/1/52.abstract N2 - Cardio-oncology is a subspecialty that provides cardiac care for patients with cancer. Newer oncological agents have not only increased survivorship, but also sprouted novel cardiovascular toxicity (CVT) involving any component of the cardiovascular system, albeit with some preferential targets. Patients with cancer should undergo a baseline cardiovascular risk assessment and have individualised surveillance planned during cancer therapy and post treatment. The early diagnosis of CVT, by clinical history and examination along with imaging and laboratory analysis, is paramount. Management includes cardioprotective strategies and multidisciplinary decision-making regarding the risk–benefit ratio of oncological treatment based on CVT. ER -